Pre-publication history
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
-
* Corresponding author: Sandro Pignata sandro.pignata@fondazionepascale.it
BMC Cancer 2006, 6:5 doi:10.1186/1471-2407-6-5
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 13 Sep 2005 | |
| Reviewer's Report | Maurie Markman | 04 Oct 2005 | |
| Reviewer's Report | Gini Fleming | 05 Oct 2005 | |
| Reviewer's Report | Paul Sabbatini | 02 Nov 2005 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 14 Nov 2005 |
| Reviewer's Report | Paul Sabbatini | 22 Nov 2005 | |
| Reviewer's Report | Gini Fleming | 01 Dec 2005 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 05 Jan 2006 |
| Resubmission - Version 5 | Manuscript | 05 Jan 2006 | |
| Resubmission - Version 6 | Manuscript | 06 Jan 2006 | |
| Published | 07 Jan 2006 |